Key Mycoplasma Testing Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The mycoplasma testing market is consolidated by the leadership of Thermo Fisher and Charles River Labs, gained through strategic acquisitions and investments in automation. Other key players, such as Merck KGaA and Sartorius, are capitalizing on their strong emphasis on GMP-compliant solutions, while firms in gaining competency via cost-effective outsourcing. Testifying to these market characteristics, in 2024, Lonza allied with Moderna to leverage its capabilities in cultivating advanced screening tools for cell therapies. Moreover, the competition is intensifying due to the growing interest in localized production, AI integration, and regulatory harmonization.
The cohort of these pioneers include:
|
Company Name (Country) |
Market Share (2024) |
Industry Focus |
|
Thermo Fisher Scientific (U.S.) |
22.6% |
PCR kits, automated testing systems for biopharma & diagnostics |
|
Charles River Laboratories (U.S.) |
18.3% |
End-to-end testing services for cell/gene therapies |
|
Merck KGaA (Germany) |
12.7% |
ELISA kits & cell culture contamination solutions |
|
Lonza Group (Switzerland) |
10.8% |
cGMP-compliant testing for contract manufacturing |
|
Sartorius AG (Germany) |
8.4% |
Automated microbial detection systems |
|
Becton Dickinson (U.S.) |
xx% |
Molecular diagnostics & lab automation tools |
|
Bio-Rad Laboratories (U.S.) |
xx% |
qPCR reagents & validation kits |
|
F. Hoffmann-La Roche (Switzerland) |
xx% |
NGS-based mycoplasma detection for biologics |
|
Agilent Technologies (U.S.) |
xx% |
Nucleic acid extraction kits & lab instruments |
|
WuXi AppTec (China) |
xx% |
Outsourced testing services for global CROs |
|
BioMérieux (France) |
xx% |
Culture-based detection systems |
|
Danaher Corporation (U.S.) |
xx% |
Integrated diagnostics platforms (Cepheid) |
|
PerkinElmer (U.S.) |
xx% |
High-throughput screening solutions |
|
Cell Signaling Technology (U.S.) |
xx% |
Antibodies & assays for research labs |
|
Promega Corporation (U.S.) |
xx% |
Luminescence-based detection kits |
|
Biocon (India) |
xx% |
Affordable ELISA kits for emerging markets |
|
InQpharm Group (Malaysia) |
xx% |
Rapid tests for Southeast Asian hospitals |
Below are the areas covered for each company in the mycoplasma testing market:
